EM1609D "Advances in the Endoscopic Management of Obesity" (IM GR-160909)

Obesity has become a worldwide epidemic with significant impact on quality of life, morbidity, and mortality rates. Over the past two decades, bariatric surgery has established itself as the most effective and durable treatment for patients with obesity and its associated comorbidities. However, despite the use of minimally invasive techniques, bariatric surgery is associated with complications, has a substantial cost and is used by only 1% of patients who are eligible. Therefore, there is a need for effective minimally invasive therapies, which will be utilized by the large proportion of obese patients who are in desperate need of treatment but are not receiving any. Endoscopic approaches to the management of obesity have been developed, with the aim of delivering more effective, durable, and safer methods of weight reduction.

The purpose of this review provides and overview of currently available and future endoscopic therapies like to be used in the management of obesity.

Download Protocol

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Discuss the variety of Endoscopic Bariatric Therapies (EBT’s) that are being developed as alternatives to Bariatric Surgery.
  • Identify the risks and benefits of EBT’s and weigh them against surgery.
  • Explain the efficacy of these EBT’s in treating obesity and its co-morbidities, like type 2 diabetes.
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
Course expires: 

Photo: Byron Cryer, M.D.Byron Cryer, M.D.
Associate Dean, Faculty Diversity & Development
Professor, Division of Digestive & Liver Diseases

Available Credit

  • 1.00 AMA


Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome